 Connection
Christina Chambers to Product Surveillance, Postmarketing
This is a "connection" page, showing publications Christina Chambers has written about Product Surveillance, Postmarketing.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.887 |
|
|
|
-
Vukusic S, Coyle PK, Jurgensen S, Truffinet P, Benamor M, Afsar S, Purvis A, Poole EM, Chambers C. Pregnancy outcomes in patients with multiple sclerosis treated with teriflunomide: Clinical study data and 5 years of post-marketing experience. Mult Scler. 2020 06; 26(7):829-836.
Score: 0.571
-
Mahadevan U, Levy G, Gensler L, Ali M, Lacerda AP, Wegrzyn L, Palac H, Bhutani-Jacques T, Long M, Clowse MEB, Kimball AB, Chambers C, Scialli AR. Pregnancy Outcomes in Patients Treated with Upadacitinib: Analysis of Data from Clinical Trials and Postmarketing Reports. Drug Saf. 2024 Oct; 47(10):1039-1049.
Score: 0.206
-
Chambers C. Safety of asthma and allergy medications in pregnancy. Immunol Allergy Clin North Am. 2006 Feb; 26(1):13-28.
Score: 0.057
-
Felix RJ, Jones KL, Johnson KA, McCloskey CA, Chambers CD. Postmarketing surveillance for drug safety in pregnancy: the Organization of Teratology Information Services project. Birth Defects Res A Clin Mol Teratol. 2004 Dec; 70(12):944-7.
Score: 0.053
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|